Background and Purpose Δ9-Tetrahydrocannabinolic acid (Δ9-THCA-A), the precursor of Δ9-THC, is a non-psychotropic phytocannabinoid that shows PPARγ agonist activity. Here,...
Cannabidiol (CBD), the major non-psychoactive compound found in cannabis, is frequently used both as a nutraceutical and therapeutic. Despite anecdotal...
Cannabis has been used to relieve the symptoms of disease for thousands of years. However, social and political biases have...
Low tetrahydrocannabinol Cannabis sativa products, also known as hemp products, have become widely available and their use in veterinary patients...
While cannabis is perceived as a relatively safe drug by the public, accumulating clinical data suggest detrimental cardiovascular effects of...
Bidirectional and functional relationships between glucocorticoids and the endocannabinoid system have been demonstrated. Here, I review the interaction between the...
Background: In recent years, growing concerns about the effects of cannabis use on mental health have renewed interest in cannabis...
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-Cov-2), was identified for the...
Cannabitwinol (CBDD, 3), the second member of a new class of dimeric phytocannabinoids in which two units are connected by...
The cardiovascular effects of two new cannabinoids, nabilone and canbisol, have been compared to 9-tetrahydrocannabinol (9-THC) and chlordiazepoxide. Unanesthetized rabbits,...
© 2025 · Veterinary Cannabis Society